Tonix Pharma Statistics
Want to see TNXP full AI Analyst Report?
Tonix Pharma (TNXP) Stock Statistics & Valuation Metrics
Total Valuation
Tonix Pharma has a market cap or net worth of $79.67M. The enterprise value is $18.07M.
- Market Cap
- $79.67M
- Enterprise Value
- $18.07M
Share Statistics
Tonix Pharma has 19,431,517 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 19,431,517
- Owned by Insiders
- 0.24%
- Owned by Institutions
- 19.53%
Financial Efficiency
Tonix Pharma’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -51.00%.
- Return on Equity (ROE)
- -0.51
- Return on Assets (ROA)
- -0.45
- Return on Invested Capital (ROIC)
- -51.00%
- Return on Capital Employed (ROCE)
- -0.51
- Revenue Per Employee
- 92.30K
- Profits Per Employee
- -873.39K
- Employee Count
- 142
- Asset Turnover
- 0.05
- Inventory Turnover
- 1.42
Valuation Ratios
The current PE Ratio of Tonix Pharma is -0.33. Tonix Pharma’s PEG ratio is -0.01.
- PE Ratio
- -0.33
- PS Ratio
- 1.63
- PB Ratio
- 0.38
- Price to FCF
- -0.41
- Price to Operating Cash Flow
- -0.46
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Tonix Pharma had revenue of 13.11M and earned -124.02M in profits. Earnings per share was -14.57.
- Revenue
- 13.11M
- Gross Profit
- 4.54M
- Operating Income
- -125.70M
- Pretax Income
- -124.02M
- Net Income
- -124.02M
- EBITDA
- -122.01M
- Earnings Per Share (EPS)
- -14.57
Cash Flow
In the last 12 months, operating cash flow was -165.28M and capital expenditures -4.76M, giving a free cash flow of -170.04M billion.
- Operating Cash Flow
- -165.28M
- Free Cash Flow
- -170.04M
- Free Cash Flow per Share
- -9.22
Dividends & Yields
Tonix Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -235.22%
- Earnings Yield
- -164.23%
Stock Price Statistics
- Beta
- 1.48
- 52-Week Price Change
- -75.65%
- 50-Day Moving Average
- 8.70
- 200-Day Moving Average
- 12.07
- Relative Strength Index (RSI)
- 16.13
- Average Volume (3m)
- 692.10K
Important Dates
Tonix Pharma upcoming earnings date is Mar 15, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Mar 15, 2027
- Ex-Dividend Date
- ―
Financial Position
Tonix Pharma as a current ratio of 7.42, with Debt / Equity ratio of 0.53%
- Current Ratio
- 7.42
- Quick Ratio
- 7.23
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.69
- Interest Coverage Ratio
- -1412.39
Taxes
In the past 12 months, Tonix Pharma has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Tonix Pharma EV to EBITDA ratio is 0.49, with an EV/FCF ratio of 0.52.
- EV to Sales
- -2.07
- EV to EBITDA
- 0.49
- EV to Free Cash Flow
- 0.52
- EV to Operating Cash Flow
- 0.54
Balance Sheet
Tonix Pharma has $162.79K in cash and marketable securities with $1,253.00 in debt, giving a net cash position of $161.54K billion.
- Cash & Marketable Securities
- $162.79K
- Total Debt
- $1,253.00
- Net Cash
- $161.54K
- Net Cash Per Share
- $0.01
- Tangible Book Value Per Share
- $0.01
Margins
Gross margin is 86.91%, with operating margin of -436.25%, and net profit margin of -296.56%.
- Gross Margin
- 86.91%
- Operating Margin
- -436.25%
- Pretax Margin
- -296.56%
- Net Profit Margin
- -296.56%
- EBITDA Margin
- -421.47%
- EBIT Margin
- -296.56%
Analyst Forecast
The average price target for Tonix Pharma is $23.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $23.50
- Price Target Upside
- 473.17% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 317.96%
- EPS Growth Forecast
- 98.76%
Scores
- Smart Score
- 6
- AI Score
- 49
